a developer of drugs to combat various diseases
Industry Biotechnology
A.I.dvisor tells us that GALT and RNAC have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GALT and RNAC's prices will move in lockstep.
Ticker / NAME | Correlation To GALT | 1D Price Change % | ||
---|---|---|---|---|
GALT | 100% | -5.17% | ||
RNAC - GALT | 32% Poorly correlated | -0.58% | ||
SNPX - GALT | 32% Poorly correlated | -4.68% | ||
PMN - GALT | 26% Poorly correlated | +1.48% | ||
ERAS - GALT | 26% Poorly correlated | -1.40% | ||
PGEN - GALT | 25% Poorly correlated | -3.58% | ||
More |
Ticker / NAME | Correlation To GALT | 1D Price Change % |
---|---|---|
GALT | 100% | -5.17% |
drugs theme (254 stocks) | 19% Poorly correlated | -4.03% |
biotechnology theme (238 stocks) | 12% Poorly correlated | -4.32% |
diseases theme (41 stocks) | 11% Poorly correlated | -3.13% |